e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Notable abstracts in COPD: variety
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Biological and phenomenological markers of ageing in patients with COPD and their relationship to CT emphysema scores
Rudolf A Jörres (Munich, Germany), Tanja Schramm, Angelika Kronseder, Frank Biertz, Hans-Ulrich Kauczor, Dennis Nowak, Rudolf Maria Huber, Martina Kerscher, Rudolf A. Jörres
Source:
International Congress 2015 – Notable abstracts in COPD: variety
Session:
Notable abstracts in COPD: variety
Session type:
Oral Presentation
Number:
1965
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Rudolf A Jörres (Munich, Germany), Tanja Schramm, Angelika Kronseder, Frank Biertz, Hans-Ulrich Kauczor, Dennis Nowak, Rudolf Maria Huber, Martina Kerscher, Rudolf A. Jörres. Biological and phenomenological markers of ageing in patients with COPD and their relationship to CT emphysema scores. Eur Respir J 2015; 46: Suppl. 59, 1965
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
How beneficial might be using the Lüscher colour test in the psychological assessment of COPD patients?
Source: International Congress 2015 – Best abstracts in COPD management
Year: 2015
The distribution of phenotypes in a population of severe COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Role of inflammatory biomarkers in COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
A multimarker approach to identify atherosclerosis in COPD
Source: International Congress 2014 – Markers
Year: 2014
Impact of comorbidities in COPD prognosys scores
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
Proteinase-inhibitor system state in patients with COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
Biomarkers in COPD exacerbation, the role of adiponectin
Source: International Congress 2014 – Predictors
Year: 2014
The role of COPD in development of osteoporosis
Source: International Congress 2014 – Markers
Year: 2014
The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients
Source: International Congress 2016 – Monitoring airway diseases with different tools
Year: 2016
Cardiovascular comorbidities prevails in the early stages of COPD irrespective of predominant airway or emphysema phenotype
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Stable state MR-proadrenomedullin level in COPD patients; a validation study
Source: International Congress 2014 – Comorbidities
Year: 2014
Does the 2011 GOLD staging of COPD reflect phenotype and severity of the disease as assessed by CT?
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT
Source: International Congress 2014 – Markers
Year: 2014
Renal impairment a neglected comorbidity in patients with COPD
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Gender differences in COPD patients
Source: International Congress 2014 – Clinical presentations
Year: 2014
Prognostic assessment in chronic obstructive pulmonary disease using copeptin: A simplified risk index
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Scales of assesment in COPD. Correlation with clinical and functional parameters
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Burden of comorbidities and NT-proBNP concentrations in stable COPD patients
Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept